1Waterer GW,Somes GW,Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Inter Med,2001,161:1837-1842.
2Niederman MS,Mandell LA,Anzueto A,et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis,assessment of severity,antimicrobial thereapy,and prevention. Am J Respir Crit Care Med,2001,163:1730-1754.
3Ichimiya T,Yamsaki T,Nasu M. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother,1994,34:331-341.
4M. A. García-Ordó?ez,J. M. García-Jiménez,F. Páez,F. álvarez,B. Poyato,M. Franquelo,J. D. Colmenero,C. Juárez. Clinical Aspects and Prognostic Factors in Elderly Patients Hospitalised for Community-Acquired Pneumonia[J] 2001,European Journal of Clinical Microbiology and Infectious Diseases(1):14～19
